| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Microbiology, Institute for Animal Health, Compton Laboratory, Berkshire RG20 7NN, UK
2 Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK
3 Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire SP4 0JQ, UK
Correspondence
Mark P. Stevens
mark-p.stevens{at}bbsrc.ac.uk
Melioidosis is a severe infectious disease of animals and humans caused by the Gram-negative intracellular pathogen Burkholderia pseudomallei. An Inv/Mxi-Spa-like type III protein secretion apparatus, encoded by the B. pseudomallei bsa locus, facilitates bacterial invasion of epithelial cells, escape from endocytic vesicles and intracellular survival. This study investigated the role of the Bsa type III secretion system in the pathogenesis of melioidosis in murine models. B. pseudomallei bipD mutants, lacking a component of the translocation apparatus, were found to be significantly attenuated following intraperitoneal or intranasal challenge of BALB/c mice. Furthermore, a bipD mutant was attenuated in C57BL/6 IL-12 p40–/– mice, which are highly susceptible to B. pseudomallei infection. Mutation of bipD impaired bacterial replication in the liver and spleen of BALB/c mice in the early stages of infection. B. pseudomallei mutants lacking either the type III secreted guanine nucleotide exchange factor BopE or the putative effectors BopA or BopB exhibited varying degrees of attenuation, with mutations in bopA and bopB causing a significant delay in median time to death. This indicates that bsa-encoded type III secreted proteins may act in concert to determine the outcome of B. pseudomallei infection in mice. Mice inoculated with the B. pseudomallei bipD mutant were partially protected against subsequent challenge with wild-type B. pseudomallei. However, immunization of mice with purified BipD protein was not protective.
These authors contributed equally to the work.
This article has been cited by other articles:
|
|
 |
|
  G. Shalom, J. G. Shaw, and M. S. Thomas In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages Microbiology, August 1, 2007; 153(8): 2689 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Espina, S. F. Ausar, C. R. Middaugh, M. A. Baxter, W. D. Picking, and W. L. Picking Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems Protein Sci., April 1, 2007; 16(4): 704 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cuccui, A. Easton, K. K. Chu, G. J. Bancroft, P. C. F. Oyston, R. W. Titball, and B. W. Wren Development of Signature-Tagged Mutagenesis in Burkholderia pseudomallei To Identify Genes Important in Survival and Pathogenesis Infect. Immun., March 1, 2007; 75(3): 1186 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Johnson, P. Roversi, M. Espina, A. Olive, J. E. Deane, S. Birket, T. Field, W. D. Picking, A. J. Blocker, E. E. Galyov, et al. Self-chaperoning of the Type III Secretion System Needle Tip Proteins IpaD and BipD J. Biol. Chem., February 9, 2007; 282(6): 4035 - 4044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Espina, A. J. Olive, R. Kenjale, D. S. Moore, S. F. Ausar, R. W. Kaminski, E. V. Oaks, C. R. Middaugh, W. D. Picking, and W. L. Picking IpaD Localizes to the Tip of the Type III Secretion System Needle of Shigella flexneri. Infect. Immun., August 1, 2006; 74(8): 4391 - 4400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Ribot and R. L. Ulrich The Animal Pathogen-Like Type III Secretion System Is Required for the Intracellular Survival of Burkholderia mallei within J774.2 Macrophages Infect. Immun., July 1, 2006; 74(7): 4349 - 4353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pilatz, K. Breitbach, N. Hein, B. Fehlhaber, J. Schulze, B. Brenneke, L. Eberl, and I. Steinmetz Identification of Burkholderia pseudomallei Genes Required for the Intracellular Life Cycle and In Vivo Virulence. Infect. Immun., June 1, 2006; 74(6): 3576 - 3586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Elvin, G. D. Healey, A. Westwood, S. C. Knight, J. E. Eyles, and E. D. Williamson Protection against Heterologous Burkholderia pseudomallei Strains by Dendritic Cell Immunization Infect. Immun., March 1, 2006; 74(3): 1706 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Alice, C. S. Lopez, C. A. Lowe, M. A. Ledesma, and J. H. Crosa Genetic and Transcriptional Analysis of the Siderophore Malleobactin Biosynthesis and Transport Genes in the Human Pathogen Burkholderia pseudomallei K96243 J. Bacteriol., February 15, 2006; 188(4): 1551 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ungewickell, C. Hugge, M. Kisseleva, S.-C. Chang, J. Zou, Y. Feng, E. E. Galyov, M. Wilson, and P. W. Majerus The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases PNAS, December 27, 2005; 102(52): 18854 - 18859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suparak, W. Kespichayawattana, A. Haque, A. Easton, S. Damnin, G. Lertmemongkolchai, G. J. Bancroft, and S. Korbsrisate Multinucleated Giant Cell Formation and Apoptosis in Infected Host Cells Is Mediated by Burkholderia pseudomallei Type III Secretion Protein BipB J. Bacteriol., September 15, 2005; 187(18): 6556 - 6560. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Cheng and B. J. Currie Melioidosis: Epidemiology, Pathophysiology, and Management Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
